Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Lite Strategy, Inc.
Market Cap
$47.98M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$48.53M
Interest Coverage Ratio
-145.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$48.76M
Interest Coverage Ratio
N/A
TTM Avg
254.37x
3Y Avg
222.37x
5Y Avg
222.37x
Market Cap
$48.89M
Interest Coverage Ratio
N/A
TTM Avg
5767.75x
3Y Avg
5767.75x
5Y Avg
5767.75x
Market Cap
$49.25M
Interest Coverage Ratio
-23.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$46.69M
Interest Coverage Ratio
-9.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lite Strategy, Inc. (LITS) | $47.98M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $48.53M | -145.74x | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | N/A | 254.37x | 222.37x | 222.37x |
| TELA Bio, Inc. (TELA)vs › | $48.77M | -6.44x | N/A | N/A | N/A |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | N/A | 5767.75x | 5767.75x | 5767.75x |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | -23.69x | N/A | N/A | N/A |
| Instil Bio, Inc. (TIL)vs › | $46.69M | -9.08x | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $49.45M | -8.61x | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $49.71M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $45.73M | -9.08x | N/A | N/A | N/A |
Interest Coverage
N/A
Debt/Equity
0.00
Current Ratio
5.74
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
